NASDAQ:UTRS Minerva Surgical (UTRS) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free UTRS Stock Alerts $0.0010 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.0010▼$0.001050-Day Range$0.00▼$0.6752-Week Range$0.00▼$14.00VolumeN/AAverage Volume2,327 shsMarket Capitalization$8,880.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Minerva Surgical alerts: Email Address Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details About Minerva Surgical Stock (NASDAQ:UTRS)Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.Read More UTRS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart UTRS Stock News HeadlinesJanuary 10, 2024 | thestreet.comMinerva Surgical Inc.December 18, 2023 | markets.businessinsider.comWhy Is Minerva Surgical (UTRS) Stock Down 50% Today?May 5, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.December 17, 2023 | morningstar.comMinerva Surgical Inc UTRSNovember 14, 2023 | finanznachrichten.deMinerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | msn.comMinerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93MNovember 13, 2023 | finance.yahoo.comMinerva Surgical Reports Third Quarter 2023 Financial ResultsSeptember 29, 2023 | finance.yahoo.comAccelmed Files Transaction Statement on Schedule 13E-3 with Securities and Exchange CommissionMay 5, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.August 3, 2023 | finance.yahoo.comMinerva Surgical Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comMinerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue EstimatesMay 25, 2023 | finance.yahoo.comInvestors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past weekMay 24, 2023 | msn.comWhy Minerva Surgical Shares Are Taking Off WednesdayMay 24, 2023 | theglobeandmail.comPatent Grant Sends Healthcare Shares Soaring PremarketMay 24, 2023 | msn.comWhy Is Minerva Surgical (UTRS) Stock Up 229% Today?May 3, 2023 | finance.yahoo.comQ1 2023 Minerva Surgical Inc Earnings CallMay 2, 2023 | finance.yahoo.comMinerva Surgical Reports First Quarter 2023 Financial ResultsApril 18, 2023 | finance.yahoo.comMinerva Surgical to Announce First Quarter 2023 Financial ResultsMarch 24, 2023 | finance.yahoo.comMinerva Surgical, Inc. (NASDAQ:UTRS) Q4 2022 Earnings Call TranscriptMarch 23, 2023 | markets.businessinsider.comPiper Sandler Remains a Buy on Minerva Surgical (UTRS)March 22, 2023 | benzinga.comMinerva Surgical Stock (NASDAQ:UTRS), DividendsMarch 22, 2023 | finanznachrichten.deMinerva Surgical, Inc.: Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial ResultsMarch 22, 2023 | finance.yahoo.comQ4 2022 Minerva Surgical Inc Earnings CallMarch 21, 2023 | finance.yahoo.comMinerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial ResultsMarch 21, 2023 | finance.yahoo.comMinerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial OfficerMarch 20, 2023 | msn.comMinerva Surgical Earnings PreviewMarch 8, 2023 | finance.yahoo.comMinerva Surgical to Announce Fourth Quarter and Full Year 2022 Financial ResultsSee More Headlines Receive UTRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Minerva Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/01/2021Today5/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:UTRS CUSIPN/A CIK1452965 Webwww.minervasurgical.com Phone855-646-7874FaxN/AEmployees174Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($8.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-34,110,000.00 Net Margins-64.71% Pretax Margin-64.61% Return on Equity-136.40% Return on Assets-43.70% Debt Debt-to-Equity Ratio1.38 Current Ratio1.88 Quick Ratio1.03 Sales & Book Value Annual Sales$50.29 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$11.52 per share Price / Book0.00Miscellaneous Outstanding Shares8,880,000Free Float8,124,000Market Cap$8,880.00 OptionableNot Optionable Beta1.14 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Todd Usen (Age 57)President, CEO & Director Mr. Greg SimbroVice President of FinanceMr. Erik ReeseVice President of SalesMs. Wendy BowmanVice President of Human ResourcesDr. Evgueni V. Skalnyi M.D. (Age 58)Chief Medical Officer Comp: $365.25kMs. Joanne LongVice President of Corporate ControllerMore ExecutivesKey CompetitorsHTG Molecular DiagnosticsNASDAQ:HTGMQGenocea BiosciencesNASDAQ:GNCAQGenocea BiosciencesNASDAQ:GNCAKaleido BiosciencesNASDAQ:KLDOAllied Healthcare ProductsNASDAQ:AHPIView All Competitors UTRS Stock Analysis - Frequently Asked Questions How have UTRS shares performed in 2024? Minerva Surgical's stock was trading at $1.17 at the start of the year. Since then, UTRS stock has decreased by 99.9% and is now trading at $0.0010. View the best growth stocks for 2024 here. How were Minerva Surgical's earnings last quarter? Minerva Surgical, Inc. (NASDAQ:UTRS) released its quarterly earnings data on Wednesday, December, 1st. The company reported ($23.00) EPS for the quarter, missing analysts' consensus estimates of ($8.80) by $14.20. The company had revenue of $12.51 million for the quarter, compared to analysts' expectations of $12.23 million. Minerva Surgical had a negative net margin of 64.71% and a negative trailing twelve-month return on equity of 136.40%. When did Minerva Surgical's stock split? Minerva Surgical's stock reverse split on the morning of Monday, October 2nd 2023. The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Minerva Surgical IPO? Minerva Surgical (UTRS) raised $100 million in an initial public offering on Friday, October 22nd 2021. The company issued 6,250,000 shares at $15.00-$17.00 per share. How do I buy shares of Minerva Surgical? Shares of UTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:UTRS) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
